Results 141 to 150 of about 11,060 (223)

Impact of Sacubitril/Valsartan on Cardiac Autonomic Function Assessed Using Physiological Data from Implantable Cardioverter-Defibrillators. [PDF]

J Clin Med
Barone L, Sergi D, Maglia G, Bontempi L, Giaccardi M, Baroni M, Amellone C, Curnis A, D'Alterio G, Saporito D, Vinciguerra P, Cipani S, Mazzone P, Giammaria M, Mitacchione G, Masarone D, Fabbri F, Vannelli A, Baldassarre I, Del Maestro M, Giacopelli D, Celentano E, Zanotto G, Barillà F.   +23 more
europepmc   +1 more source

Inappropriate shocks from subcutaneous and transvenous implantable cardioverter-defibrillators: Reports from the FDA MAUDE database. [PDF]

Heart Rhythm O2
Hauser RG, Desouki M, Stanberry LI, Abdelsayed K, Kapphahn-Bergs M, Witt D, Sengupta JN.   +6 more
europepmc   +1 more source

Extravascular implantable cardioverter-defibrillators implantation in a pacing-dependent patient with a cardiac resynchronization therapy system: A structured intraoperative protocol to validate device-device interaction. [PDF]

Heart Rhythm O2
Wu X, Cai Y, Ou Z, Qiu Z.
europepmc   +1 more source

Subcutaneous implantable cardioverter defibrillator

, 2016
openaire   +1 more source

Symptom Experiences and Coping Strategies in Turkish Patients with Implantable Cardioverter-Defibrillators: A Cross-Sectional Study Based on Interviews. [PDF]

Healthcare (Basel)
Us SA, Taşcı S.
europepmc   +1 more source

Enhanced Detection of Atrial Fibrillation and Tachyarrhythmia Differentiation Using Atrial Electrograms in Single-chamber Implantable Cardioverter-defibrillators: A Retrospective Analysis. [PDF]

J Innov Card Rhythm Manag
Konanur Srinivasa NK, Dilay Dirican C, Prakash A.   +2 more
europepmc   +1 more source

Long-term low-voltage impedance measurements in subcutaneous implantable cardioverter-defibrillators [PDF]

Europace
Mugnai G, Tomasi L, Ottaviano L, Viani S, Ricciardi G, Bianchi V, Rella V, De Filippo P, De Bonis S, Rordorf R, Pecora D, Botto G, Nigro G, Tola G, Caravati F, Lovecchio M, Valsecchi S, Ziacchi M, “S-ICD Rhythm Detect” Investigators.   +18 more
europepmc   +2 more sources

Extravascular Implantable Cardioverter-Defibrillators: A Systematic Review of Emerging Evidence. [PDF]

Cureus
Jaganathan N, Goel V, Sorrentino R, Gallo D, Devarapalli M.   +4 more
europepmc   +1 more source

Impact of Kidney Function on the Survival of Patients with Chagas Cardiomyopathy and Implantable Cardioverter Defibrillators. [PDF]

J Clin Med
Martin Tapioca FP, Santana Passos LC, Cafezeiro C, Carvalho W, Novis Rocha P, Guimarães MG.   +5 more
europepmc   +1 more source

Implantable Cardioverter-Defibrillators for Secondary Prevention in Giant Cell Myocarditis. [PDF]

Cureus
Shukla K, Basile EJ, Khasawneh T, Lin M, Brand SJ.   +4 more
europepmc   +1 more source